Gan & Lee Pharmaceuticals gibt bei den 84. Scientific Sessions der American Diabetes Association wichtige Fortschritte bei neuen Diabetes- und Adipositas-Behandlungen bekannt

Posted on by

PEKING und BRIDGEWATER, New Jersey, 24. Juni 2024 /PRNewswire/ — Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) stellte die Ergebnisse der klinischen Phase-1b/2a-Studie des unabhängig entwickelten, Glucagon-ähnlichen Peptide-1-(GLP-1-)Rezeptoragonisten GZR18…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.